Market Access/ News/ News CHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugar Phil Taylor Baqsimi, Diabetes, Eli Lilly, hypoglycaemia, Xeris Pharma 0 Comment The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as the first needle-free treatment Share X CHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugar https://pharmaphorum.com/news/chmp-backs-lillys-baqsimi-as-non-injectable-for-severe-low-blood-sugar/
Market Access/ News/ News Xeris’ severe low blood sugar pen gets FDA approval Phil Taylor Baqsimi, Diabetes, Eli Lilly, glucagon, hypoglycaemia, Xeris Pharma 0 Comment After 14 years of operations Xeris Pharma has its first-ever product approval, claiming an FDA okay for a Share X Xeris’ severe low blood sugar pen gets FDA approval https://pharmaphorum.com/news/xeris-severe-low-blood-sugar-pen-gets-fda-approval/
Baqsimi, Diabetes, Eli Lilly, hypoglycaemia, Xeris Pharma
0 Comment
